Chemical inhibitors of SR-BI include a range of compounds that interact with the protein in various ways to impede its function. BLT-1 and its structurally similar compound Block lipid transport-1 are known to directly inhibit SR-BI by obstructing the selective uptake of high-density lipoprotein (HDL) cholesterol esters. This blockade prevents SR-BI from fulfilling its role in cholesterol transport, a crucial step in lipid metabolism. Similarly, ITX5061 hinders SR-BI by preventing HDL binding and cholesterol uptake, which are fundamental to the protein's operation in lipid transport. Glyburide also exerts its inhibitory effects by interfering with the binding of HDL, which is essential for SR-BI's role in cholesterol ester uptake.
Progesterone and Dehydroepiandrosterone (DHEA) exploit a different inhibitory mechanism; they compete with cholesterol for binding sites on SR-BI, thus inhibiting cholesterol uptake. This competition disrupts the normal functioning of SR-BI in lipid transfer across cell membranes. Niclosamide adds to this arsenal by disrupting cholesterol trafficking, a process central to lipid homeostasis and one in which SR-BI plays a pivotal role. Betulinic Acid, through its impact on cholesterol efflux, and Guggulsterone, by interacting with cholesterol binding sites, both contribute to the inhibition of SR-BI's lipid handling capabilities. The functioning of SR-BI is further challenged by compounds such as Phloretin and Rutin, which disrupt lipid transport and cholesterol uptake mechanisms. Phloretin achieves this by interfering with the protein's lipid transport system, while Rutin impairs the binding of lipoproteins to SR-BI, thereby obstructing cholesterol uptake. Ellagic Acid rounds out the list of inhibitors by altering SR-BI's ability to mediate lipid transfer across cellular membranes. Each of these chemicals contributes to the inhibition of SR-BI by targeting specific aspects of its function in lipid metabolism, resulting in a comprehensive blockade of its activity in cholesterol handling and transport processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DHEA | 53-43-0 | sc-202573 | 10 g | $111.00 | 3 | |
DHEA inhibits SR-BI by competing with cholesterol for binding and uptake, thus impeding lipid transfer. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic Acid can inhibit SR-BI by altering cholesterol efflux, affecting the protein's lipid handling. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Glyburide inhibits SR-BI by interfering with the binding of HDL and blocking cholesterol ester uptake. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide inhibits SR-BI by disrupting cholesterol trafficking, affecting lipid homeostasis. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone binds to SR-BI and inhibits the selective uptake of cholesterol from HDL. | ||||||
Guggulsterone | 95975-55-6 | sc-203990 sc-203990A | 10 mg 50 mg | $145.00 $615.00 | 1 | |
Guggulsterone inhibits SR-BI's lipid uptake function by interacting with cholesterol binding sites. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin inhibits SR-BI by disrupting the protein's lipid transport and cholesterol uptake mechanisms. | ||||||
Rutin trihydrate | 250249-75-3 | sc-204897 sc-204897A sc-204897B | 5 g 50 g 100 g | $57.00 $72.00 $126.00 | 7 | |
Rutin inhibits SR-BI by impairing the binding of lipoproteins and consequently the cholesterol uptake. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic Acid can inhibit SR-BI by altering its ability to mediate the transfer of lipids across the membrane. | ||||||